News & Events

Putnam Welcomes New Partner, Antonio Iervolino

July 12, 2022
|
Firm News

Putnam, a leader in the life sciences strategic advisory services, has welcomed Antonio Iervolino as a Partner in our London office.

Antonio joins Putnam with over 15 years of experience in senior roles across management consulting (IMS and IQVIA), corporate pharma (Mundipharma) and information services (Evaluate). For the last 4 years at IQVIA, he has led strategy consulting operations across regional and global clients in the Nordics, UK, and Benelux and headed the EMEA Brand & Commercial Strategy practice. With advisory services experience across the commercial strategy spectrum, he brings depth of expertise in go-to-market design, launch excellence, asset development, and portfolio strategy. Antonio’s educational background is in international economics and business management with executive education in R&D Strategy (INSEAD), Innovation (MIT), and Machine Learning (Stanford).

When asked what he is most passionate about, Antonio shares, “I am deeply passionate about enabling companies to fully capture the value of scientific innovation that is being generated at a relentless pace by the life science industry. Today, successfully launching a new medicine requires cutting through several complex issues – engaging a wider range of increasingly demanding stakeholders with sharper medical and commercial capabilities, generating clinically and economically meaningful evidence, and shaping care pathways to ultimately drive the best possible experience for patients.”

Antonio continues by adding, “I firmly believe Putnam, and the wider Inizio group, have a very unique breadth of capabilities coupled with rare depth to help biotech and pharma companies tackle some of the most pressing challenges. The firm has maintained the nimbleness and entrepreneurial mindset of a consulting boutique, but with the scale of a large enterprise. It is the start of an exciting journey, and I am thrilled to be part of it.”

Putnam leadership and the wider employee community are looking forward to Antonio being part of this journey. With an office in London and clients across the globe, Putnam continues to expand their presence in Europe. They are looking forward to Antonio’s impact on the European market – and on the firm overall.

Remco op den Kelder, CEO adds, “We are very excited to welcome Antonio to our team. Over the past 24 months, we have been significantly growing our team in Europe – and Antonio joining our team out of our London office is another step towards maturing our European presence. Antonio brings with him more than a decade of experience in developing commercial strategies for the global and European markets.  His commercial strategy experience perfectly complements the significant strengths our existing Putnam team in Europe has in developing value pricing and access strategies across key markets.”

About Putnam

Putnam is a premier strategy consulting firm serving biopharmaceutical, diagnostics, medtech, and private equity / venture capital clients. For over 30 years, we have provided objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle. We are proudly part of Inizio Advisory, an ecosystem of healthcare advisory businesses offering the finest depth of expertise you need, all under one roof.

Strategy for the Life Sciences